Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT00707759
Eligibility Criteria:
Inclusion Criteria:
* Age \< 16.0 years
* Bone age of boys \< 15 years, of girls \< 13 years
* Prepuberal Tanner Status I
* First or second kidney transplant, living or deceased kidney donation
* Immunosuppression with Tacrolimus (TAC),Mycophenolate mofetil (MMF)
* Patients and parents, respectively, have given their written consent after enlightenment (informed consent)
Exclusion Criteria:
* Irreversible rejection of former transplant
* Highly reactive (\> 30%) lymphocytotoxic antibodies within 12 months prior to transplantation
* Suspected insufficient medication compliance in dialysis
* Patients receiving a basic immunosuppression other than that prescribed in this protocol
* Simultaneous therapy with growth hormone after renal transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
16 Years
Study:
NCT00707759
Study Brief:
Protocol Section:
NCT00707759